Alzheimer's disease, in the labyrinthine world of neuroscience where memories dance across synapses and consciousness remains ...

Most shocking to CARD workers was the termination of lead researcher Kendall Van Keuren-Jensen, who was announced internally ...

A 75-year-old man with a genetic predisposition for Alzheimer’s has yet to show signs of the disease. Could this offer ...

A hidden phase of Alzheimer’s appears decades before symptoms, offering a chance for early detection and treatment.

A man who should have developed early-onset Alzheimer's disease due to a genetic mutation is still symptom-free in his 70s.

Researchers from the UK and Slovenia have identified disrupted brain-blood flow coordination and increased breathing rates as ...

Despite the potential benefits of early detection and increasing treatment options for Alzheimer's disease and related ...

A medical research center named after former U.S. Sen. Roy Blunt of Missouri is facing drastic workforce reductions as part ...

Feb. 11, 2025 — A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way ...

If you’re looking for a poster child for something this administration is doing that has no apparent support from anyone, I think you’ve got your winner.

Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time. Those medications, however, are not without their risks and side effects.

Iowa native is the third member of his family to be diagnosed with Alzheimer's. Now, his community is rallying around him.